Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP739661.RAfW8KXyASHF-gXvS13Ytks6r8zwI0F5D-On9azJEKXMY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP739661.RAfW8KXyASHF-gXvS13Ytks6r8zwI0F5D-On9azJEKXMY130_assertion type Assertion NP739661.RAfW8KXyASHF-gXvS13Ytks6r8zwI0F5D-On9azJEKXMY130_head.
- NP739661.RAfW8KXyASHF-gXvS13Ytks6r8zwI0F5D-On9azJEKXMY130_assertion description "[By inhibiting the BCL9-?-catenin interaction and selectively suppressing oncogenic Wnt transcription, SAH-BCL9 may serve as a prototype therapeutic agent for cancers driven by deregulated Wnt signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP739661.RAfW8KXyASHF-gXvS13Ytks6r8zwI0F5D-On9azJEKXMY130_provenance.
- NP739661.RAfW8KXyASHF-gXvS13Ytks6r8zwI0F5D-On9azJEKXMY130_assertion evidence source_evidence_literature NP739661.RAfW8KXyASHF-gXvS13Ytks6r8zwI0F5D-On9azJEKXMY130_provenance.
- NP739661.RAfW8KXyASHF-gXvS13Ytks6r8zwI0F5D-On9azJEKXMY130_assertion SIO_000772 22914623 NP739661.RAfW8KXyASHF-gXvS13Ytks6r8zwI0F5D-On9azJEKXMY130_provenance.
- NP739661.RAfW8KXyASHF-gXvS13Ytks6r8zwI0F5D-On9azJEKXMY130_assertion wasDerivedFrom befree-20140225 NP739661.RAfW8KXyASHF-gXvS13Ytks6r8zwI0F5D-On9azJEKXMY130_provenance.
- NP739661.RAfW8KXyASHF-gXvS13Ytks6r8zwI0F5D-On9azJEKXMY130_assertion wasGeneratedBy ECO_0000203 NP739661.RAfW8KXyASHF-gXvS13Ytks6r8zwI0F5D-On9azJEKXMY130_provenance.